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There is considerable evidence that abnormal biometal homeostasis is a key feature of many
neurodegenerative diseases and may have an important role in the onset and progression of
disorders such as Alzheimer’s (AD), Parkinson’s (PD), prion, and motor neuron diseases. The role
of biometals in a growing list of brain disorders is supported by evidence from a wide range of
sources including molecular genetics, biochemical studies and biometal imaging. These studies
have spurred a growing interest in understanding the role of biometals in brain function and
disease as well as the development of therapeutic approaches that may be able to restore the altered
biometal chemistry of the brain. In this Research Topic, Metals and Neurodegeneration: Restoring
the Balance, we probe the biochemical basis of metal-mediated neurodegeneration, examine genetic
links between metal dyshomeostasis and brain disorders, investigate metal trafficking and metal-
synaptic interactions, and their role in neurodegeneration, and examine some of the key new
approaches to understanding how metals drive neurodegenerative changes. We hope that these
exciting insights will provide a strong platform to develop advances in therapeutics that will allow
us to “restore the balance” in metal homeostasis in the brain.
One of the most prominent features across many neurodegenerative disorders is loss of metal
homeostasis, and in many cases, the metal revealing the most substantial change is iron (Fe).
Opening this Research Topic, Hare et al. (2013) provides an excellent overview of Fe transport
and Fe-regulatory processes in the brain, and demonstrates clearly the complexity in these
processes. The review describes how abnormalities in this complex process can lead to loss of
Fe, which is associated with changes in neurotransmission, energy production and myelination,
and is associated with diseases such as AD. Conversely, abnormal Fe handling can also lead
to Fe accumulation, which is associated with AD and PD and is a major target of therapeutic
developments based on Fe chelation. Expanding on Fe in neurodegeneration is the review by
Muhoberac and Vidal (2013), who explore the genetic basis of Fe dyshomeostasis in hereditary
ferritinopathy. The article provides a timely insight into the effects of abnormal Fe metabolism
through loss of ferritin function, a key Fe-regulatory protein and how these changes can lead
to ferritin accumulation, reactive oxygen species formation and oxidative stress. Mariani et al.
(2013), further explores hereditary links between Fe and neurodegeneration. They describe links
between Fe-specific gene variations (e.g., transferrin, hemochromatosis) and Fe regulatory proteins
(ceruloplasmin and apolipoprotein E) in AD, PD and mild cognitive impairment. Despite a small
cohort and rare alleles the studies provide important insights on altered Fe in neurodegeneration
and illustrate that the role of metals in neurodegeneration must be examined in association with
genetics, and disease sub-populations to gain a clear insight into the contributory role of metals in
these diseases. When we think of metals and neurodegeneration, we often focus on the brain, but
metal changes in the eye are also prominent in these disorders. Song and Dunaief (2013) describe
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the role of Fe in retinal degeneration in hereditary Fe overload
disorders and the potential impact of Fe accumulation in acute
macular degeneration.
Other metal changes also feature strongly in
neurodegenerative diseases. Telianidis et al. (2013) provides an
excellent overview of the key copper (Cu) transport proteins,
ATP7a and ATP7b in cellular Cu homeostasis. They provide
important insights into the cell fate when abnormal Cu
trafficking occurs, as is evidenced by the genetic diseases,
Menkes and Wilson disease, and more broadly in AD and
prion diseases. Dringen et al. (2013) extends this to describe the
essential role of Cu uptake, transport, metabolism, and export
by astrocytes in the brain and how this has a major impact in
neuronal survival and function. Cu is also an essential metal in
synaptic function as illustrated by the exciting new research by
Castro et al. (2014). They describe how Cu modulates zinc (Zn)
homeostasis (another key metal involved in neurotransmission)
in hippocampal neurons, and report that Cu has significant
effects on expression of key synaptic proteins, synapsin, and
dynamin. Zn and its contribution to neurodegeneration is
also the topic covered by Szewczyk (2013), who describes how
uncontrolled influx of Zn during traumatic brain injury and
stroke, can exacerbate neuronal cell death. In contrast, Zn
deficiency may also have a key role in neurodegeneration. This
is covered by Szewczyk, with an insight into how changes to Zn
transporters and metallothionein may contribute to altered Zn
homeostasis in neurodegeneration.
As with Fe, Cu and Zn, less common biometals such
as manganese (Mn) appear to have a growing role in
neurodegenerative processes. Rather than intoxication from
high doses, metals such as Mn can have extraordinary
outcomes on complex cortical structures and associated cognitive
function even at very low doses. This is covered in depth by
Guilarte (2013). These effects may have an important role in
neurodegenerative changes in AD and Parkinsonism.
Altered biometal homeostasis is not only a factor in
the leading forms or neurodegeneration. They have a key
role in many rarer forms of neurodegeneration including
childhood neurodegenerative disorders. Parker et al. (2013),
report on the role of metals in neuronal ceroid lipofuscinosis,
neurodegeneration with brain iron accumulation (NBIA), and
additional diseases, further extending the links between genetic
mutations and metal abnormalities in these disorders.
Obviously, while this is a rapidly expanding field of research,
as illustrated here, we still have much further to go to achieve
a major understanding of where these biometal changes fit into
the neurodegenerative disease process. Are they prime drivers
of disease, significant contributors, a downstream outcome, or
(likely) a mix of these? These questions will only be answered
through the application of highly sensitive analytical and genetic
approaches. Lothian et al. (2013), describe how this can be
achieved with the relatively new and rapidly advancing field of
metalloproteomics to dissect metal-protein interactions. Chen
et al. (2013) then concludes with an excellent description of the
powerful genetic model of C. elegans and how this is used to pin-
point assessment of altered metal homeostasis and its associated
genes in a simple but elegant model system.
It has been extraordinarily difficult to get the mainstream
fields of neuroscience and medicine to understand the key role
biometals have in neurodegeneration.We hope that this Research
Topic will help to inform and expand the knowledge on how
biometals contribute to neurodegeneration, and inspire others
to enter this rapidly growing and exciting field of research.
New insights are needed as a basis for innovative therapeutic
approaches that hopefully will help to “restore the balance” in
these widespread diseases.
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